| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/26/2004 | DE10238994A1 New mono- and bis-rylenedicarbimidyl-anthraquinone dyes for coloring (in)organic material, e.g. plastics, or coating system or as organic pigment dispersant or additive or electrophotographic photoconductor |
| 02/26/2004 | DE10103770B4 Verfahren zur Herstellung von hochreinem Methenamin A process for the production of high purity methenamine |
| 02/26/2004 | CA2493246A1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391461A1 Bicyclic lactam inhibitors of interleukin-1-beta converting enzyme |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1390369A1 4-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 02/25/2004 | EP1232158B1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 02/25/2004 | EP1206469B1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 02/25/2004 | EP1140931B1 5ht1 antagonists for antidepressant therapy |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | EP0954336B1 Membrane incorporation of texaphyrins |
| 02/25/2004 | EP0831834B1 Debromohymenialdisine and related compounds for treating osteoarthritis |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1477106A Synthesis method of tetraalkyl tetrazaporphyrin metal coordination compound |
| 02/25/2004 | CN1139591C Method for acylating hexakis (arylmethyl) hexaazaisowurtzitane |
| 02/25/2004 | CN1139590C Process for preparing citrat |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696565 Method and associated pyrimido[4,5-d]pyrimidine-2,5-diones and pyrido[4,3-d]pyrimidin-2-ones for forming nanotubes |
| 02/24/2004 | US6696478 Compound targeted to protein kinase c enzyme |
| 02/24/2004 | US6696476 Pyranoindazoles and their use for the treatment of glaucoma |
| 02/24/2004 | US6696455 Nitrogen compounds such as 6-chloro-2-methyl-4-oxo-pyrido (3,2-d)pyrimidine used as anticarcinogenic agents and/or for prophylaxis of infections caused by pneumocystis or toxoplasma |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696444 Neurotransmitter antagonists comprising compounds such as 4,2'-difluoro-5'-(3-(1-fluoro-1-methylethyl)imidazo(1,2-b)(1,2 ,4) triazin-7-yl)biphenyl-2-carbonitrile, administered for the prophylaxis of headaches or as anticonvulsants |
| 02/24/2004 | US6696441 Inhibition of p53-induced stress response |
| 02/24/2004 | US6696039 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 02/24/2004 | CA2199399C .beta.,.beta.'-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from .beta.,.beta.'-unsubstituted tetrapyrrolic macrocyles |
| 02/19/2004 | WO2004014923A1 Pyrimidinone fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014915A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 02/19/2004 | WO2004014914A1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 02/19/2004 | WO2004014900A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014380A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 02/19/2004 | WO2004014354A1 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2004014294A2 4,7-disubstituted indoles and methods of making |
| 02/19/2004 | WO2004000840A3 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 02/19/2004 | WO2003086306A3 5ht2c receptor modulators |
| 02/19/2004 | WO2003057213A3 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 02/19/2004 | WO2003057149B1 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones |
| 02/19/2004 | US20040034225 Aryl-substituted n, n-heterocyclic compounds, method for their preparationand their use in therapeutics and diagnostics |
| 02/19/2004 | US20040034061 An antagonist of corticotropin releasing factor receptor, treating depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disorders, drug dependence |
| 02/19/2004 | US20040034055 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 02/19/2004 | US20040034037 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040034012 Superior arginine vasopressin receptor antagonism; a 6-membered aromatic ring having nitrogen at the 2-position there of is substituted at 2 position of the imidazobenzazepine ring |
| 02/19/2004 | US20040034009 1,6-Fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | US20040034006 Combining blood product with (a porphyrin compound) a photosensitiser, and activating the photosensitiser |
| 02/19/2004 | US20040034005 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 02/19/2004 | US20040033964 For treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation |
| 02/19/2004 | US20040033962 Antibody directed enzyme prodrug therapy |
| 02/19/2004 | US20040033935 Novel imidazole derivatives, production method thereof and use thereof |
| 02/19/2004 | US20040033934 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof |
| 02/19/2004 | US20040033910 Bicyclic thioamides as additives for lubricating oils |
| 02/19/2004 | CA2495516A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | CA2495502A1 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | CA2494636A1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 02/19/2004 | CA2492837A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 02/18/2004 | EP1389208A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists) |
| 02/18/2004 | EP1389194A2 Inhibitors of bace |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP1389179A1 Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters |
| 02/18/2004 | EP1389100A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
| 02/18/2004 | EP1389099A1 Delivery of beta-blockers through an inhalation route |
| 02/18/2004 | EP1389098A1 Delivery of antipsychotics through an inhalation route |
| 02/18/2004 | EP1389097A1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 02/18/2004 | EP1389096A1 Delivery of opioids through an inhalation route |
| 02/18/2004 | EP1389095A1 Delivery of antidepressants through an inhalation route |
| 02/18/2004 | EP1389094A1 Delivery of sedative-hypnotics trough an inhalation route |
| 02/18/2004 | EP1216248B1 Triazolopyrimidine derivatives |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | EP0944631B1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
| 02/18/2004 | CN1475477A Method and intermdeiate used for manufacturing antifolic acid agent |
| 02/18/2004 | CN1138779C Substituted triazolo-pyridazing derivative, pharmaceutical composition made therefrom |
| 02/18/2004 | CN1138778C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/18/2004 | CN1138777C Photoactivatable nitrogen-containing bases based on alpha-amino ketones |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/17/2004 | US6693202 Multibinding ligands containing such as amine, amide, ester, hydroxyl, carbamate, urea and/or imino functionality |
| 02/17/2004 | US6693193 Coupling an n- and o-protected 2,3-dihydroxy-pyrrolidine to the 2-position and deprotecting |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693111 Indole-2,3-dione-3-oxime derivatives |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6692540 Dyeing composition containing a pyrazolo-[1,5-A]pyrimidine as oxidation base and a pyridine coupling agent, and dyeing method |
| 02/17/2004 | US6692538 Use of novel indole compounds for dyeing and making up keratin materials, compositions comprising them and dyeing processes |
| 02/12/2004 | WO2004013300A2 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 02/12/2004 | WO2004013282A2 Bis (amino acid) molecular scaffolds |
| 02/12/2004 | WO2004013235A1 Fibre-reactive azo dyes, their preparation and their use |
| 02/12/2004 | WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 02/12/2004 | WO2004013145A1 Pyrrolotriazine kinase inhibitors |